Swen-Olof Andersson
Overview
Explore the profile of Swen-Olof Andersson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holmberg L, Garmo H, Andersson S, Andren O, Johansson E, Taari K, et al.
N Engl J Med
. 2024 Oct;
391(14):1362-1364.
PMID: 39383464
No abstract available.
2.
Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, et al.
N Engl J Med
. 2018 Dec;
379(24):2319-2329.
PMID: 30575473
Background: Radical prostatectomy reduces mortality among men with clinically detected localized prostate cancer, but evidence from randomized trials with long-term follow-up is sparse. Methods: We randomly assigned 695 men with...
3.
Davidsson S, Carlsson J, Molling P, Gashi N, Andren O, Andersson S, et al.
Front Microbiol
. 2017 Dec;
8:2241.
PMID: 29201018
Inflammation is one of the hallmarks of prostate cancer. The origin of inflammation is unknown, but microbial infections are suspected to play a role. In previous studies, the Gram-positive, low...
4.
Davidsson S, Andren O, Ohlson A, Carlsson J, Andersson S, Giunchi F, et al.
Prostate
. 2017 Nov;
78(1):40-47.
PMID: 29105795
Background: The tumor promoting or counteracting effects of the immune response to cancer development are thought to be mediated to some extent by the infiltration of regulatory T cells (T...
5.
Lu D, Carlsson J, Penney K, Davidsson S, Andersson S, Mucci L, et al.
Cancer Epidemiol Biomarkers Prev
. 2017 Sep;
26(12):1781-1787.
PMID: 28939587
Recent data suggest that neuroendocrine signaling pathways may play a role in the progression of prostate cancer, particularly for early-stage disease. We aimed to explore whether expression of selected genes...
6.
Stopsack K, Gerke T, Andren O, Andersson S, Giovannucci E, Mucci L, et al.
Carcinogenesis
. 2017 Jun;
38(8):806-811.
PMID: 28595267
Lethal prostate cancers have higher expression of squalene monooxygenase (SQLE), the second rate-limiting enzyme of cholesterol synthesis. Preclinical studies suggested that aberrant cholesterol regulators, receptors and transporters contribute to cholesterol...
7.
Zareba P, Flavin R, Isikbay M, Rider J, Gerke T, Finn S, et al.
Cancer Epidemiol Biomarkers Prev
. 2017 Jan;
26(5):719-726.
PMID: 28062398
Prostate cancer has a propensity to invade and grow along nerves, a phenomenon called perineural invasion (PNI). Recent studies suggest that the presence of PNI in prostate cancer has been...
8.
Ali I, Julin B, Glynn A, Hogberg J, Berglund M, Johansson J, et al.
Carcinogenesis
. 2016 Oct;
37(12):1144-1151.
PMID: 27742691
Polychlorinated biphenyls (PCBs) are highly persistent environmental pollutants and are undesirable components of our daily food. PCBs are classified as human carcinogens, but the evidence for prostate cancer is limited...
9.
Davidsson S, Molling P, Rider J, Unemo M, Karlsson M, Carlsson J, et al.
Infect Agent Cancer
. 2016 Jun;
11:36.
PMID: 27335583
[This corrects the article DOI: 10.1186/s13027-016-0074-9.].
10.
Stopsack K, Gerke T, Sinnott J, Penney K, Tyekucheva S, Sesso H, et al.
Cancer Res
. 2016 Jun;
76(16):4785-90.
PMID: 27325648
Cholesterol metabolism has been implicated in prostate cancer pathogenesis. Here, we assessed the association of intratumoral mRNA expression of cholesterol synthesis enzymes, transporters, and regulators in tumor specimen at diagnosis...